Company intelligence / Profile preview

Kalabie Klee Group

Le Plessis-Robinson, France

Ownership: Private
Development stage: Other

Overview

Kalabie, originally a division of the Klee Group, is a provider of Electronic Laboratory Notebook (ELN) software designed specifically for R&D sectors in the life sciences, pharmaceutical, and chemical industries. The platform facilitates the digital capture, management, and sharing of experimental data, helping organizations streamline laboratory workflows and ensure intellectual property protection. Following its acquisition by LabVantage in 2007, the Kalabie ELN has been integrated into a broader suite of laboratory information management systems (LIMS). The software is widely used by research scientists to replace paper notebooks with a searchable, compliant, and collaborative digital environment.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Kalabie Klee Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kalabie Klee Group.

Explore the full profile